Carotuximab (TRC105)

Carotuximab · Tracon Pharmaceuticals Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Carotuximab (TRC105), covering 2020-06-24 to 2020-06-24. Get the full timeline:

Most recent: Clinical Trial Update: Study of Carotuximab (TRC105) Plus Nivolumab in Patients With Metastatic NSCLC [Phase 1]